{"id":"NCT01231620","sponsor":"GlaxoSmithKline","briefTitle":"A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza","officialTitle":"A Phase III International, Randomized, Double-blind, Double-dummy Study to Evaluate the Efficacy and Safety of 300 mg or 600 mg of Intravenous Zanamivir Twice Daily Compared to 75 mg of Oral Oseltamivir Twice Daily in the Treatment of Hospitalized Adults and Adolescents With Influenza","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-01-15","primaryCompletion":"2015-03-18","completion":"2015-03-18","firstPosted":"2010-11-01","resultsPosted":"2017-11-20","lastUpdate":"2018-10-15"},"enrollment":626,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Influenza, Human"],"interventions":[{"type":"DRUG","name":"Zanamivir","otherNames":["Relenza"]},{"type":"DRUG","name":"Placebo to match zanamivir","otherNames":[]},{"type":"DRUG","name":"Oseltamivir","otherNames":["Tamiflu"]},{"type":"DRUG","name":"Placebo to match oseltamivir","otherNames":[]}],"arms":[{"label":"Intravenous (IV) Zanamivir 300mg Twice Daily","type":"EXPERIMENTAL"},{"label":"Intravenous (IV) Zanamivir 600mg Twice Daily","type":"EXPERIMENTAL"},{"label":"Oral Oseltamivir 75mg Twice Daily","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to test the safety and efficacy of zanamivir given intravenously and how well it works at two different doses in hospitalized adolescents and adults with flu. Zanamivir will be compared with oseltamivir, which is used for treating flu.","primaryOutcome":{"measure":"Time to Clinical Response (TTCR) in Participants With Confirmed Influenza","timeFrame":"Up to 42 days","effectByArm":[{"arm":"IV Zanamivir 300 mg","deltaMin":5.87,"sd":null},{"arm":"IV Zanamivir 600 mg","deltaMin":5.14,"sd":null},{"arm":"Oral Oseltamivir 75 mg","deltaMin":5.63,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.25"},{"comp":"OG001 vs OG002","p":"0.39"}]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":13},"locations":{"siteCount":170,"countries":["United States","Australia","Belgium","Brazil","Canada","China","Colombia","Czechia","Denmark","France","Germany","Greece","Hong Kong","Hungary","India","Mexico","Netherlands","New Zealand","Norway","Poland","Russia","Slovakia","South Africa","South Korea","Spain","Taiwan","Thailand","United Kingdom"]},"refs":{"pmids":["36202198","28094141"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":38,"n":201},"commonTop":["Diarrhoea","Constipation"]}}